PMID- 34227020 OWN - NLM STAT- MEDLINE DCOM- 20210927 LR - 20211222 IS - 1708-0428 (Electronic) IS - 0960-8923 (Linking) VI - 31 IP - 9 DP - 2021 Sep TI - Predictors of Type 2 Diabetes Mellitus Remission After Metabolic Surgery in Asian Patients with a BMI < 32.5 kg/m(2). PG - 4125-4133 LID - 10.1007/s11695-021-05544-1 [doi] AB - BACKGROUND: Metabolic surgery is an effective treatment for type 2 diabetes mellitus (T2DM) in patients with obesity. However, the efficacy in patients with body mass index (BMI) < 32.5 kg/m(2), especially in Asian populations, has not been widely reported, and there are few studies on the prediction of diabetes remission. METHODS: We evaluated 112 patients with T2DM who underwent metabolic surgery between October 2008 and November 2019. The basic data of the patients were collected, and clinical variables were measured at 6 months, 1 year, and 2 years after metabolic surgery. Four independent predictors of surgical outcomes were identified to construct the prediction score. RESULTS: Diabetes remission occurred for 38 of the 112 patients. Ninety patients underwent Roux-en-Y gastric bypass, while the remaining 22 patients underwent sleeve gastrectomy. Weight, glucose, and lipid metabolism parameters were improved significantly after metabolic surgery. Age, BMI, insulin use, and duration were independent predictors of T2DM remission. The above four factors were defined with scores and developed ABID (age, BMI, insulin use, duration) scoring system. Patients with greater ABID scores had a greater probability of diabetes remission (from 0% at score 0 to 100% at score 4). CONCLUSIONS: The ABID score is a simple and easy-to-implement prediction score system of diabetes remission after metabolic surgery for T2DM patients with a BMI < 32.5 kg/m(2). CI - (c) 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Yu, Zhaomei AU - Yu Z AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. FAU - Li, Weizheng AU - Li W AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. FAU - Sun, Xulong AU - Sun X AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. FAU - Tang, Haibo AU - Tang H AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. FAU - Li, Pengzhou AU - Li P AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. FAU - Ji, Guangnian AU - Ji G AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. jiguangnian@126.com. AD - Department of Hepatobiliary & Pancreatic Surgery, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, China. jiguangnian@126.com. FAU - Zhu, Liyong AU - Zhu L AUID- ORCID: 0000-0003-2696-4177 AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. zly8128@126.com. FAU - Zhu, Shaihong AU - Zhu S AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210705 PL - United States TA - Obes Surg JT - Obesity surgery JID - 9106714 SB - IM MH - *Bariatric Surgery MH - Body Mass Index MH - *Diabetes Mellitus, Type 2/surgery MH - Humans MH - *Obesity, Morbid/surgery MH - Remission Induction OTO - NOTNLM OT - Low body mass index OT - Metabolic surgery OT - Prediction score OT - Type 2 diabetes mellitus EDAT- 2021/07/07 06:00 MHDA- 2021/09/28 06:00 CRDT- 2021/07/06 06:43 PHST- 2021/02/11 00:00 [received] PHST- 2021/06/16 00:00 [accepted] PHST- 2021/06/11 00:00 [revised] PHST- 2021/07/07 06:00 [pubmed] PHST- 2021/09/28 06:00 [medline] PHST- 2021/07/06 06:43 [entrez] AID - 10.1007/s11695-021-05544-1 [pii] AID - 10.1007/s11695-021-05544-1 [doi] PST - ppublish SO - Obes Surg. 2021 Sep;31(9):4125-4133. doi: 10.1007/s11695-021-05544-1. Epub 2021 Jul 5.